U.S. flag

An official website of the United States government

NM_020686.5(ABAT):c.659G>A (p.Arg220Lys) AND Gamma-aminobutyric acid transaminase deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 11, 2009
Review status:
1 star out of maximum of 4 stars
classified by single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000017603.26

Allele description

NM_020686.5(ABAT):c.659G>A (p.Arg220Lys)

Gene:
ABAT:4-aminobutyrate aminotransferase [Gene - OMIM]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.2
Genomic location:
Preferred name:
NM_020686.5(ABAT):c.659G>A (p.Arg220Lys)
HGVS:
  • NC_000016.10:g.8768248G>A
  • NG_008432.1:g.98662G>A
  • NM_000663.4:c.659G>A
  • NM_020686.5:c.659G>A
  • NP_000654.2:p.Arg220Lys
  • NP_065737.2:p.Arg220Lys
  • NC_000016.9:g.8862105G>A
Protein change:
R220K; ARG220LYS
Links:
OMIM: 137150.0001; dbSNP: rs121434578
NCBI 1000 Genomes Browser:
rs121434578
Molecular consequence:
  • NM_020686.5:c.659G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Gamma-aminobutyric acid transaminase deficiency
Synonyms:
GABA-transaminase deficiency
Identifiers:
MedGen: C0342708; Orphanet: 2066; OMIM: 613163
Age of onset:
Childhood
Prevalence:
<1 / 1 000 000 2066

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037876OMIM
Pathogenic
(Dec 11, 2009)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism.

Jaeken J, Casaer P, de Cock P, Corbeel L, Eeckels R, Eggermont E, Schechter PJ, Brucher JM.

Neuropediatrics. 1984 Aug;15(3):165-9.

PubMed [citation]
PMID:
6148708

4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency.

Medina-Kauwe LK, Tobin AJ, De Meirleir L, Jaeken J, Jakobs C, Nyhan WL, Gibson KM.

J Inherit Metab Dis. 1999 Jun;22(4):414-27. Review.

PubMed [citation]
PMID:
10407778

Details of each submission

From OMIM, SCV000037876.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a patient with GABA-transaminase deficiency (613163) reported by Jaeken et al. (1984), Medina-Kauwe et al. (1999) identified a 754A-G transition in the ABAT gene, resulting in an arg220-to-lys (R220K) substitution in a highly conserved residue. Expression of the mutant in E. coli, followed by isolation and enzymatic characterization of the recombinant protein, revealed an enzyme whose Vmax was reduced to 25% of wildtype activity. The second allele in the patient remained unidentified.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 20, 2014